CoChat

How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators

Cooney, Marie Therese, Dudina, Alexandra, De Bacquer, Dirk, Fitzgerald, Anthony, Conroy, Ronan, Sans, Susana, Menotti, Alessandro, De Backer, Guy, Jousilahti, Pekka, Keil, Ulrich, Thomsen, Troels, Whincup, Peter, Graham, Ian, SCORE investigators · 2009 · European Journal of Cardiovascular Prevention & Rehabilitation

The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Systematic COronary Risk Evaluation (SCORE), the risk estimation system recommended by the European guidelines on cardiovascular disease prevention, estimates 10-year risk of cardiovascular disease mortality based on age, sex, country of origin, systolic blood pressure, smoking status and either total cholesterol (TC) or TC/high-density lipoprotein cholesterol (HDL-C) ratio. As, counterintuitively, these two systems perform very similarly, we have investigated whether incorporating HDL-C and TC as separate variables improves risk estimation. METHODS: The study consisted of 57,302 men and 47,659 women. Cox proportional hazards method was used to derive the function including HDL-C and an identical function without HDL-C for comparison. Risk charts were developed to illustrate the results. RESULTS: Inclusion of HDL-C resulted in a modest but statistically significant improvement in risk estimation, based on the area under receiver operating characteristic curve (AUROC); 0.814 versus 0.808, P value less than 0.0001, for the functions with and without HDL-C, respectively. Addition of HDL-C also resulted in a significant and important improvement in risk estimation as measured by net reclassification index, which is highly clinically relevant. Improvement in risk estimation was greatest in women from high-risk countries, in terms of both AUROC and net reclassification index. CONCLUSION: For the general population, the inclusion of HDL-C in risk estimation results in only a modest improvement in overall risk estimation based on AUROC. However, when using the more clinically that examines reclassification of individuals, clinically useful improvements occur. Inclusion of HDL may be particularly useful in women from high-risk countries and individuals with unusually high or low HDL-C levels. Addition of HDL-C is particularly applicable to electronic, interactive risk estimation systems such as HeartScore.

Overview

Integrity signals

Registry

Crossref · 10.1097/hjr.0b013e3283213140

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 45 references

Research works printed but not linked: 6

  1. Koro CE, 2006, Am Heart J, 151
  2. Cooney MT, 2007, European Heart Journal, 28, 127
  3. Rodes A, 1990, Rev Epidemiol Sante Publique, 38, 447
  4. Schroll M, 1992, Dan Med Bull, 39, 204
  5. Presentation of the rifle project risk factors and life expectancy., 1993, Eur J Epidemiol, 9, 459
  6. Panagiotakos D, 2007, Hellenic J Cardiol, 48, 55

Cited by

See all 150

Metadata

Authors
Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., Thomsen, T., Whincup, P., Graham, I., & SCORE investigators
Affiliations
  • Tallaght University Hospital (IE)
  • Department of Public Health, University of Ghent, Gent, Belgium
  • University College Cork (IE)
  • Department of Epidemiology, Royal College of Surgeons, Dublin
  • Departament de Salut (ES)
  • Association for Cardiac Research, Rome, Italy
  • Department of Epidemiology and Health Promotion, National Public Health Institute, Finland
  • University of Münster (DE)
  • Glostrup Hospital (DK)
  • St George's, University of London (GB)
Venue
European Journal of Cardiovascular Prevention & Rehabilitation
Published
2009-06
Volume
16
Issue
3
Pages
304-314
ISSN
1741-8267 (ISSN-L)
OpenAlex
W2098173132
Cited by
121
References
45
Citations by year
2025: 1 · 2024: 1 · 2023: 2 · 2021: 5 · 2020: 5 · 2019: 5 · 2018: 4 · 2017: 9 · 2016: 14 · 2015: 8 · 2014: 9 · 2013: 12 · 2012: 17
FWCI
15.17
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • European Journal of Cardiovascular Prevention & Rehabilitation (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
Funders
British Heart Foundation (RG/08/013/25942)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Keywords
HDL cholesterol, SCORE risk score, cardiovascular risk prediction, total cholesterol, net reclassification improvement, risk charts, women, high-risk countries, HeartScore, cardiovascular disease prevention
MeSH terms
Cardiovascular Diseases, Cholesterol, Europe, Female, Humans, Cholesterol, HDL, Male, Risk Factors, ROC Curve, Biomarkers, Proportional Hazards Models, Risk Assessment, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. https://app.cochat.ai/papers/10.1097/hjr.0b013e3283213140
The paper
Cooney, M. T., Dudina, A., De Bacquer, D., Fitzgerald, A., Conroy, R., Sans, S., Menotti, A., De Backer, G., Jousilahti, P., Keil, U., Thomsen, T., Whincup, P., Graham, I., & SCORE investigators. (2009). How much does HDL cholesterol add to risk estimation? A report from the SCORE investigators. European Journal of Cardiovascular Prevention & Rehabilitation. https://doi.org/10.1097/hjr.0b013e3283213140

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.